Monolith | Binding Affinity
-
ReadNanoTemper announces Monolith X with breakthrough Spectral Shift technology, enabling affinity measurements where other methods fail
NanoTemper Technologies introduced Monolith X, adding breakthrough Spectral Shift technology to their top-selling Monolith product line.
-
2:20WatchIntroducing Monolith X - the only way to get binding affinities in solution using very minimal sample
-
Read
The only way to get binding affinities in solution using very minimal sample
-
Ready to characterize your most challenging interactions?
Learn more
Discover tools to measure binding affinity -
Read
The researcher’s guide to measuring binding affinity and why it matters
-
ReadNanoTemper’s Monolith wins top global design award: Red Dot Award
NanoTemper’s newest Monolith instrument has been awarded the Red Dot Award, an internationally recognized seal of excellence in design. Both bold aesthetics and user-friendly design have always...
-
Read10 terms to help you more easily understand targeted protein degradation
Targeted Protein Degradation (TPD), a relatively new therapeutic approach, is making waves by targeting otherwise ‘undruggable’ proteins. PROTACs are the best-understood protein degraders, with...
-
14:01WatchHow to study molecular interactions of membrane proteins without compromising their native structure
The desire to use technology that allows you to study membrane proteins in close-to-native conditions is specifically important when it comes to interaction measurements. It’s always a question how mu
-
Read
Because you need to characterize the most challenging interactions
-
35:47WatchImprove your protein degrader design with new ways to discover E3 ligase ligands
Targeted protein degradation using molecular glues or proteolysis-targeting chimeras (PROTACs) is an increasingly important therapeutic modality, especially for undruggable targets. Even with candidat
-
ReadA new spectral shift-based method to characterize molecular interactions
-
ReadWhy so many companies are betting on PROTACs as a superior therapeutic modality
With PROTACs currently in the clinical and preclinical stages, they are making exciting progress towards successfully treating patients who have been waiting for effective therapies for certain...
-
35:24WatchEffect of different SARS-CoV-2 variants on COVID 19 assays and vaccines
SARS-CoV-2, the causative agent of COVID-19, has an ssRNA genome of almost 30kb that encodes for a total of 26 proteins. Among the four structural viral protein, in particular the S protein stands out
-
ReadMST and TRIC technology to reliably study PROTAC binary and ternary binding in drug development
-
27:20WatchMolecular interactions - a simple framework: Energy, energy, energy
Explore the complexities and drivers of molecular interactions with Dr. Tom Laue from the University of New Hampshire. He presented as a keynote speaker in the Protein Stability & Function: Can't have
-
5:33WatchSee the new Monolith — characterize your most challenging interactions
-
33:11WatchMaximize stability & function of SARS-CoV-spike protein and ACE2 receptor using Monolith & Prometheus
Dr. Leah Pandiscia and Dr. Daniel Turman review how to integrate the Prometheus Panta and Monolith instruments in a characterization workflow demonstration, showing how to maximize stability and funct
-
ReadNanoTemper’s Monolith wins top global design award: iF DESIGN AWARD 2021
NanoTemper’s newest Monolith instrument has been awarded the globally renowned iF DESIGN AWARD 2021. User-friendly design has always been a core focus in NanoTemper’s product development....
-
25:40WatchMischievous membrane proteins (and how to tame them)
Are you struggling to tame your mischievous membrane proteins? Find out how NanoTemper can help you to characterize even the most challenging membrane protein samples. You will learn how Prometheus ca
-
ReadTargeted protein degradation promises to lead the way to effective drugs for challenging targets
-
Read
How to build an effective protein degrader
-
Loading more...
